ARTICLE | Strategy
Rebasing pharma's growth
May 13, 2002 7:00 AM UTC
Blue Shift
If both investors and management of pharma can't wait for 2002 to end, there is one silver lining to this year's likely dismal growth numbers: it will be easier to grow off a smaller base in 2003...